MeSH tree: D12.776.070.400
In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (LeqembiTM, from Biogen) and donanemab (Kisunla, from Eli Lilly and Co.), both based on immunotherapy (the use of molecules ...
Jun 6, 2026
0
10
With dementia cases expected to nearly triple worldwide by 2050, researchers are increasingly focused on identifying ways to prevent or delay the disease. While lifestyle and health-related factors, such as blood pressure ...
Jun 5, 2026
0
6
When looking at genetic variants in a person's DNA that predispose them to disease, a new study has found having a higher number of genetic variants for increased pulse pressure is associated with a small, increased risk ...
Jun 3, 2026
0
3
Alzheimer's disease begins to weave a web in the brain and remodel neuronal tissue 15 to 20 years before the first symptoms appear. From the time this happens, however, until the disease is diagnosed and, later, enters an ...
May 21, 2026
0
3
A research team at the Brain Research Institute, Niigata University has found that APOE ε4, a genetic factor best known for increasing the risk of Alzheimer's disease, may also influence how pathological changes spread in ...
May 20, 2026
0
4
People who carry the APOE2 version of the apolipoprotein E gene are more likely to live to advanced age and are partly protected against Alzheimer's disease, but scientists have struggled to explain why. A new study from ...
May 17, 2026
0
22
Having a biological age older than chronological age is associated with a greater likelihood of developing dementia, a new study has shown. By combining measures of biological aging and genetic risk, researchers have identified ...
May 13, 2026
0
7
Scientists at the Buck Institute for Research on Aging, along with collaborators at UC San Francisco, have discovered that APOE4, the most common genetic risk factor for Alzheimer's disease, causes bone quality deficits specifically ...
Apr 13, 2026
0
8
Rutgers-Newark researchers have shown that a genetic variant specific to African ancestry alters the brain in a way that could foretell the eventual development of Alzheimer's Disease. At the same time, their study revealed ...
Mar 18, 2026
0
6
Researchers from the University of California San Diego have found that a novel blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear.
Mar 10, 2026
0
37
